HIV Women CME Webcast: Optimizing Health and Quality of Life for Women at Risk for HIV/AIDS
Credits: EXPIRED.
Release Date:
July 12, 2011
Expiration Date: July 12, 2012
Activity Code:

Optimizing Health and Quality of Life for Women at Risk for HIV/AIDS: Perspectives from Southern New Jersey (10MC34-DE01)

Optimizing Health and Quality of Life for Women at Risk for HIV/AIDS: Perspectives from Central New Jersey (10MC34-DE02)

Optimizing Health and Quality of Life for Women at Risk for HIV/AIDS: Perspectives from Northern New Jersey (10MC34-DE03)

Sponsored by Rutgers-Center for Continuing and Outreach Education (Rutgers CCOE).

In 2010, Rutgers CCOE was
re-accredited by the Accreditation Council for Continuing Medical Education (ACCME) and received Accreditation with Commendation status, the highest rating achievable by a provider of CME.

Commercial Support:
This activity is supported by an educational grant from Bristol-Myers Squibb, Inc.

There are no fees for participating and receiving CME/CE credit for this activity.

Provider Contact Information:
Please direct any technical questions, or content or CE related questions or concerns to UMDNJ at 973-972-4267 or email

Privacy Policy:
To review UMDNJ’s privacy policy, go to:



PLEASE NOTE: This activity is provided for informational purposes only.

Please expand each window to review the required course information before viewing the activity:

Statement of Need:

Women of all ages are diagnosed with HIV infection, making up approximately 26% of the epidemic in the United States, with a disproportionate 65% who are African-American. Epidemiology reports continue to document that the risk factors associated with HIV infection are well-known, including a history of intravenous drug use or sexually transmitted infections, and social factors including poverty.  The CDC has recommended routine HIV testing for everyone age 13-64, and increased testing in pregnancy and for those with the highest risk behaviors.  Despite these recommendations, HIV testing has not become universal, and women are often diagnosed years after infection, delaying treatment that could extend their health and lives.  Primary care providers should implement the screening recommendations for all their female patients, regardless of their perceived risk.  They should also provide targeted risk-reduction interventions for women with specific risk factors associated with HIV/AIDS.

Target Audience:

Primary care physicians (family practice, internists, OB-GYNs), nurse practitioners, nurses, pharmacists, social workers, and other healthcare providers who care for women of any age living with HIV/AIDS or at high risk.
Learning Objectives:

Upon completion of these activities, participants should be able to:

  • Increase HIV screening rates for women at all life stages by implementing CDC recommendations for routine, universal HIV testing for all people age 13-64, and all women in prenatal care.

  • Identify specific risk factors associated with epidemiological data of women with HIV/AIDS.

  • Utilize targeted HIV education and screening strategies appropriate for women with specific risk factors.

  • Incorporate new evidence-based strategies to reduce HIV infection among women at increased risk.

Program Description and Overall Goal:
This series of three knowledge-based CME/CE certified activities has been developed to provide an analysis of practice barriers that have delayed the implementation of universal HIV testing of women in primary care and prenatal services.  Three clinicians who treat women with HIV/AIDS offer perspectives on how to identify, assess, and engage women in HIV treatment.  They examine the epidemiology of women with HIV/AIDS, patterns that correlate with increased risk of infection, and interventions to increase screening and effective risk reduction interventions.

EXPIRED. Credit is no longer available for this activity.


  • Charletta Ayers, MD is Associate Professor of the Department of Obstet­rics, Gynecology and Reproductive Sciences at Robert Wood Johnson Medical School (UMDNJ).

  • Sally Hodder, MD is Professor of Medicine, Director of HIV Programs, and Vice-Chair of the Department of Medicine at The New Jersey Medical School (UMDNJ)

  • Judith Lightfoot, DO is an Infectious Diseases Specialist at Garden State Infectious Diseases Associates, P.A.
Peer Review:

In order to help ensure content objectivity, independence, and fair balance, and to ensure that the content is aligned with the interest of the public, Rutgers CCOE has resolved all potential and real conflicts of interest through content review by a non-conflicted, qualified reviewer. These activities were peer-reviewed for relevance, accuracy of content and balance of presentation by Gina M. Anderson, MD. Dr. Anderson was an Assistant Professor at Rutgers-New Jersey Medical School, in the department of Obstetrics, Gynecology and Women's Health.

Field Test:

This activity was pilot-tested for time required for participation by:

  • Physician:
    Tameka Simpson, DO
    Zeina Ghayad, DO

  • Pharmacist:
    George Rusuloj, PharmD
    Konstantinos Tzaferos, PharmD

  • Nurse:
    Anna Haywood, RN, MSN
    Paulette Dawn Slowinski, RN, MSN
    Maurcia Jenkins, RN, BSN

  • Social Work:
    National Association of Social Workers
Method of Instruction:

This three-part educational series is based on the content presented at the live events held at the three UMDNJ medical schools during the fall of 2010.

The estimated time to complete each activity is 1.0 hours.


Disclosure Disclaimer:

In accordance with the disclosure policies of UMDNJ and to conform with ACCME and FDA guidelines, individuals in a position to control the content of this educational activity are required to disclose to the activity participants: 1) the existence of any relevant financial relationship with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients, with the exemption of non-profit or government organizations and non-health care related companies, within the past 12 months; and 2) the identification of a commercial product/device that is unlabeled for use or an investigational use of a product/device not yet approved.


Charletta Ayers, MD has disclosed the following financial relationships:  Grant/Research Support: Bayer Corporation and Wyeth; Member, Scientific Advisory Board:  Bayer Corporation.

Sally Hodder, MD has disclosed the following financial relationships: Consultant: Boehringer Ingleheim Pharmaceuticals, Inc., Gilead Sciences, Inc., and Tibotec Therapeutics; Grant/Research Support: Gilead Sciences, Inc., and Tibotec Therapeutics; Spouse – Member, Board of Directors, Becton, Dickerson and Company; Spouse – Stock Shareholder: Merck and Co., Inc. 

Judith Lightfoot, DO has no relevant financial relationships to disclose.

Peer Reviewer, Gina M. Anderson, MD, has no relevant financial relationships to disclose.

Field Testers, Tameka Simpson, DO; Zeina Ghayad, DO; George Rusuloj, PharmD; Konstantinos Tzaferos, PharmD; Anna Haywood, RN, MSN; Paulette Dawn Slowinski, RN, MSN; Maurcia Jenkins, RN, BSN; have no relevant financial relationships to disclose.

Rutgers-Center for Continuing and Outreach Education staff members, John McInerney, Director of Marketing and E-Learning, Brenda Christian, MEd, PA-C,  Director of AIDS Education; Patrick Dwyer, Director, Continuing Medical Education; Kathleen Emerick, BS, MS, Senior Program Manager, Michelle Thompson, Program Coordinator; Sarah Quinless, Administrative Analyst; Elizabeth S. Ward, Assistant Director, CME Compliance; and have no relevant financial relationships to disclose.


Off Label Use Disclosure:

This activity does not contain information of commercial products/devices that are unlabeled for use or investigational uses of products not yet approved. 

Content Disclaimer:

The views expressed in these activities are those of the faculty. It should not be inferred or assumed that they are expressing the views of Bristol-Myers Squibb, Inc, any other manufacturer of pharmaceuticals or devices, or UMDNJ.

It should be noted that the recommendations made herein with regard to the use of therapeutic agents, varying disease states, and assessments of risk, are based upon a combination of clinical trials, current guidelines, and the clinical practice experience of the participating presenters. The drug selection and dosage information presented in this activity are believed to be accurate.  However, participants are urged to consult all available data on products or procedures before using them in clinical practice.

Copyright © 2011 Rutgers-Center for Continuing and Outreach Education.  All rights reserved including translation into other languages.  No part of this activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopying, recording, or any information storage and retrieval systems, without permission in writing from Rutgers-Center for Continuing and Outreach Education.


Technical Requirements:

These activities are Adobe Flash based presentations. In order to view, your browser must have Flash Player installed. If you do not have the Adobe Flash Player, you can download this free plug-in from These programs are best viewed at a resolution of 1024 x 768 or higher using Microsoft Internet Explorer 6 or later. A high-speed Internet connection, such as ISDN, T-1, DSL or Cable, is recommended.

Flash Player 7 or later is recommended, along with one of the following browsers (the stated version or later):

  • Windows: Internet Explorer 6, Firefox 1, Google Chrome, Safari 3, Opera 9.5, Netscape 7, AOL 8,
    CompuServe 7
  • Macintosh: Firefox 1, Google Chrome, Safari 3, Opera 9.5, Netscape 7, AOL 7, Linux: Firefox 1, Opera 9.5, Konqueror 3.3.1

Provider/Technical Contact Information:
Please direct any technical questions, or content or CE related questions or concerns to UMDNJ at 973-972-4267 or email

Before launching the CME/CE Webcast, please check the box to verify that you have reviLaunch CME Webcastewed the required course information. Thank you.